These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8958306)
1. Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors. Hung WC; Chai CY; Huang JS; Chuang LY Hum Pathol; 1996 Dec; 27(12):1324-8. PubMed ID: 8958306 [TBL] [Abstract][Full Text] [Related]
2. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862 [TBL] [Abstract][Full Text] [Related]
3. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121 [TBL] [Abstract][Full Text] [Related]
4. Amplification and expression of c-Ki-ras oncogene in human ovarian cancer. Chien CH; Chang KT; Chow SN Proc Natl Sci Counc Repub China B; 1990 Jan; 14(1):27-32. PubMed ID: 1696386 [TBL] [Abstract][Full Text] [Related]
5. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer. Chen CH; Shen J; Lee WJ; Chow SN Int J Gynecol Cancer; 2005; 15(5):878-83. PubMed ID: 16174239 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
10. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 protein expression and function in human breast cancer. Bartkova J; Lukas J; Müller H; Lützhøft D; Strauss M; Bartek J Int J Cancer; 1994 May; 57(3):353-61. PubMed ID: 8168995 [TBL] [Abstract][Full Text] [Related]
12. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells. Dhar KK; Branigan K; Parkes J; Howells RE; Hand P; Musgrove C; Strange RC; Fryer AA; Redman CW; Hoban PR Br J Cancer; 1999 Dec; 81(7):1174-81. PubMed ID: 10584879 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
14. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927 [TBL] [Abstract][Full Text] [Related]
15. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition. Macdonald FH; Yao D; Quinn JA; Greenhalgh DA Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529 [TBL] [Abstract][Full Text] [Related]
16. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Nikaido T; Li SF; Shiozawa T; Fujii S Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597 [TBL] [Abstract][Full Text] [Related]
18. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. Hu YL; Albanese C; Pestell RG; Jaffe RB J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391 [TBL] [Abstract][Full Text] [Related]
19. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Bartkova J; Lukas J; Strauss M; Bartek J Int J Cancer; 1994 Aug; 58(4):568-73. PubMed ID: 8056453 [TBL] [Abstract][Full Text] [Related]
20. Cyclin alterations in giant cell tumor of bone. Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]